Biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Tuesday its dividend for the second quarter of 2023.
The board of directors has declared a dividend of USD2.13 per share.
The dividend will be paid to shareholders of record at 18 May 2023 on 8 June 2023.
Amgen focuses on areas of high unmet medical needs and is committed to discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
AbbVie Inc announces quarterly cash dividend
Qilian International announces special one-time cash dividend
Eli Lilly collaborates with International Agencies (Bangladesh) Ltd
Sanofi reports Q4 sales of Dupixent up 42%
AmeriHealth Caritas Promotes Access to COVID-19 Vaccines for Children Ahead of the Winter Months
Eli Lilly collaborates with EVA Pharma to deliver sustainable supply of affordable insulin to Africa